These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15479851)

  • 21. Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency.
    Schelcher C; Valencia S; Delecluse HJ; Hicks M; Sinclair AJ
    J Virol; 2005 Nov; 79(21):13822-8. PubMed ID: 16227304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A molecular link between malaria and Epstein-Barr virus reactivation.
    Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
    PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replication of a chimeric origin containing elements from Epstein-Barr virus ori P and bovine papillomavirus minimal origin.
    Kivimäe S; Allikas A; Kurg R; Ustav M
    Virus Res; 2001 May; 75(1):1-11. PubMed ID: 11311423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins.
    Gao Z; Krithivas A; Finan JE; Semmes OJ; Zhou S; Wang Y; Hayward SD
    J Virol; 1998 Nov; 72(11):8559-67. PubMed ID: 9765394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the expression of the Epstein-Barr virus early gene BFRF1.
    Granato M; Farina A; Gonnella R; Santarelli R; Frati L; Faggioni A; Angeloni A
    Virology; 2006 Mar; 347(1):109-16. PubMed ID: 16406456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
    Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
    J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication.
    Kudoh A; Daikoku T; Ishimi Y; Kawaguchi Y; Shirata N; Iwahori S; Isomura H; Tsurumi T
    J Virol; 2006 Oct; 80(20):10064-72. PubMed ID: 17005684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
    Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
    Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.
    Prang N; Wolf H; Schwarzmann F
    J Virol; 1995 Apr; 69(4):2644-8. PubMed ID: 7884918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular mechanism of Epstein-barr virus DNA replication].
    Tsurumi T
    Uirusu; 2002 Jun; 52(1):191-201. PubMed ID: 12227172
    [No Abstract]   [Full Text] [Related]  

  • 32. Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt.
    Rennekamp AJ; Lieberman PM
    J Virol; 2011 Mar; 85(6):2837-50. PubMed ID: 21191028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.
    Petosa C; Morand P; Baudin F; Moulin M; Artero JB; Müller CW
    Mol Cell; 2006 Feb; 21(4):565-72. PubMed ID: 16483937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The activation of lytic replication of Epstein-Barr virus by baculovirus-mediated gene transduction.
    Wang L; Shan L; Yin J; Zhao M; Su D; Zhong J
    Arch Virol; 2006 Oct; 151(10):2047-53. PubMed ID: 16673043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Epstein-Barr virus-induced Ca2+/calmodulin-dependent kinase type IV/Gr promotes a Ca(2+)-dependent switch from latency to viral replication.
    Chatila T; Ho N; Liu P; Liu S; Mosialos G; Kieff E; Speck SH
    J Virol; 1997 Sep; 71(9):6560-7. PubMed ID: 9261377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter.
    Ruf IK; Rawlins DR
    J Virol; 1995 Dec; 69(12):7648-57. PubMed ID: 7494273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.
    Hammerschmidt W; Sugden B
    Cell; 1988 Nov; 55(3):427-33. PubMed ID: 2846181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for DNA hairpin recognition by Zta at the Epstein-Barr virus origin of lytic replication.
    Rennekamp AJ; Wang P; Lieberman PM
    J Virol; 2010 Jul; 84(14):7073-82. PubMed ID: 20444899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demethylation of the Epstein-barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report.
    Falk KI; Ernberg I
    Arch Virol; 1999; 144(11):2219-27. PubMed ID: 10603176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.